Vysis UroVysion
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $500.00 | 1 | 0 |
| 2019 | $2,371 | 23 | 21 |
| 2018 | $6,244 | 7 | 3 |
| 2017 | $184,672 | 16 | 11 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $150,000 | 1 | 77.4% |
| Consulting Fee | $19,000 | 1 | 9.8% |
| Unspecified | $9,891 | 8 | 5.1% |
| Travel and Lodging | $9,289 | 1 | 4.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,500 | 1 | 2.3% |
| Food and Beverage | $1,107 | 35 | 0.6% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Evaluation of the UroVysion Test in Predicting Recurrence and/or Progression of Disease in Patients Receiving initial BCG for Primary High Grade Ta-T1 and CIS Urothelial Carcinoma of the Bladder | Abbott Laboratories | $8,656 | 0 |
| Evaluation of the UroVysion Test in Predicting Recurrence and or Progression of Disease in Patients Receiving initial BCG for Primary High Grade Ta-T1 and CIS Urothelial Carcinoma of the Bladder | Abbott Laboratories | $1,235 | 0 |
Top Doctors Receiving Payments for Vysis UroVysion
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Houston, TX | $159,891 | 9 |
| , MD | Urology | Iowa City, IA | $19,000 | 1 |
| , M.D | Urology | Minneapolis, MN | $9,289 | 1 |
| , M.D | Urology | Houston, TX | $4,942 | 3 |
| , PH.D | Clinical Cytogenetics | Phoenix, AZ | $48.56 | 2 |
| , MD | Anatomic Pathology & Clinical Pathology | Austin, TX | $24.75 | 1 |
| , MD | Anatomic Pathology & Clinical Pathology | Austin, TX | $24.74 | 1 |
| , MD | Pediatrics | Abilene, TX | $24.74 | 1 |
| , M.D | Student in an Organized Health Care Education/Training Program | Denver, CO | $23.26 | 1 |
| , MD | Cytopathology | Denver, CO | $23.26 | 1 |
| , M.D | Urology | Rochester, MN | $22.88 | 1 |
| , MD | Urology | Rochester, NY | $22.88 | 1 |
| , M.D | Urology | Los Angeles, CA | $22.88 | 1 |
| , M.D | Urology | Durham, NC | $22.88 | 1 |
| , MD | Urology | New Orleans, LA | $22.87 | 1 |
| , MD | Urology | Dallas, TX | $22.87 | 1 |
| , MD | Anatomic Pathology | San Antonio, TX | $19.35 | 1 |
| , MD | Anatomic Pathology & Clinical Pathology | San Antonio, TX | $19.35 | 1 |
| , MD | Urology | Bellevue, WA | $18.86 | 1 |
| , M.D | Urology | Bellevue, WA | $18.85 | 1 |
| , M.D | Urology | Bellevue, WA | $18.85 | 1 |
| , MD | Urology | Bellevue, WA | $18.85 | 1 |
| , MD | Urology | La Grange, IL | $18.73 | 1 |
| , MD | Anatomic Pathology & Clinical Pathology | Virginia Beach, VA | $17.95 | 1 |
| , M.D | Urology | Virginia Beach, VA | $17.95 | 1 |
Manufacturing Companies
- Abbott Laboratories $193,787
Product Information
- Type Device
- Total Payments $193,787
- Total Doctors 35
- Transactions 47
About Vysis UroVysion
Vysis UroVysion is a device associated with $193,787 in payments to 35 healthcare providers, recorded across 47 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2017 to 2020. In 2020, $500.00 was paid across 1 transactions to 0 doctors.
The most common payment nature for Vysis UroVysion is "Royalty or License" ($150,000, 77.4% of total).
Vysis UroVysion is associated with 2 research studies, including "Evaluation of the UroVysion Test in Predicting Recurrence and/or Progression of Disease in Patients Receiving initial BCG for Primary High Grade Ta-T1 and CIS Urothelial Carcinoma of the Bladder" ($8,656).